Successful Treatment of Child Neuro-Behcet's Disease with Infliximab
Journal of Rheumatic Diseases
;
: 209-213, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-190174
ABSTRACT
Behcet's disease is a systemic vasculitis, characterized by recurrent oral aphthous ulcers, recurrent genital ulcers, skin lesion, and ocular involvement. Monoclonal antibody to the tumor necrosis factor-alpha (TNF-alpha) is considered as a possible therapeutic approach to achieve clinical improvement, preventing relapse in Behcet's disease refractory to conventional anti-inflammatory drugs or immunosuppressive durgs. We report the use of infliximab, which is one of the TNF-alpha monoclonal antibodies, in a 17-year-old girl with Behcet's disease exhibiting severe mucocutaneous, ocular and neurological involvement refractory to standard treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Recurrencia
/
Úlcera Cutánea
/
Estomatitis Aftosa
/
Factor de Necrosis Tumoral alfa
/
Vasculitis Sistémica
/
Infliximab
/
Anticuerpos Monoclonales
Límite:
Adolescente
/
Niño
/
Femenino
/
Humanos
Idioma:
Coreano
Revista:
Journal of Rheumatic Diseases
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS